Skip to content
-
Get Breaking News Alerts
Subscribe to SRKANALYTICS.COM Push Notifications and never miss important updates.
SRK Analytics SRK Analytics

Money Roar

  • Home
  • Business Insights
  • Market
  • Startup
  • Emerging Market
  • IPOs
  • Corporate Updates
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

Emerging Market

  • Home
  • Emerging Market
  • Page 4
Mars Wrigley to Shift Headquarters to Chicago, Cutting 307 New Jersey Jobs
Posted inEmerging Market

Mars Wrigley to Shift Headquarters to Chicago, Cutting 307 New Jersey Jobs

Mars Wrigley is cutting over 300 jobs in New Jersey as the candy giant consolidates its North American headquarters in Chicago.
Posted by Prasenjit Bhowmik July 24, 2026
EU Clears Paramount-Warner Bros. Discovery Merger Amid Growing U.S. Legal Opposition
Posted inEmerging Market

EU Clears Paramount-Warner Bros. Discovery Merger Amid Growing U.S. Legal Opposition

The EU has approved the Paramount and Warner Bros merger, highlighting a growing regulatory rift as US legal opposition intensifies.
Posted by Prasenjit Bhowmik July 24, 2026
EU Approves Paramount-Warner Bros. Discovery Merger Amid Growing U.S. Antitrust Resistance
Posted inEmerging Market

EU Approves Paramount-Warner Bros. Discovery Merger Amid Growing U.S. Antitrust Resistance

The EU has approved the massive Paramount-Warner Bros merger, but a fierce antitrust battle in the US could still block the historic Hollywood deal.
Posted by Prasenjit Bhowmik July 24, 2026
Senate Advances China Auto Bill Threatening Unintended Ban on Mercedes-Benz
Posted inEmerging Market

Senate Advances China Auto Bill Threatening Unintended Ban on Mercedes-Benz

A new Senate bill targeting Chinese auto influence could accidentally ban Mercedes-Benz from the US market due to its foreign ownership ties.
Posted by Prasenjit Bhowmik July 24, 2026
Japanese and Korean Automakers Dominate Surging U.S. Hybrid Vehicle Market
Posted inEmerging Market

Japanese and Korean Automakers Dominate Surging U.S. Hybrid Vehicle Market

In early 2024, three major Asian auto manufacturing groups—Toyota, Honda, and Hyundai-Kia—are capturing the vast majority of the rapidly expanding U.S. hybrid electric vehicle market. American consumers across the country…
Posted by Prasenjit Bhowmik July 24, 2026
Navigating IRS Scrutiny: How Wealthy Landowners Can Safely Utilize Conservation Easements
Posted inEmerging Market

Navigating IRS Scrutiny: How Wealthy Landowners Can Safely Utilize Conservation Easements

Learn how wealthy landowners can safely secure conservation easement tax relief and avoid IRS scrutiny by following strict federal guidelines.
Posted by Prasenjit Bhowmik July 24, 2026
JPMorgan CEO Jamie Dimon Warns Against Buying Stocks and Treasurys Amid Mounting Risks
Posted inEmerging Market

JPMorgan CEO Jamie Dimon Warns Against Buying Stocks and Treasurys Amid Mounting Risks

JPMorgan CEO Jamie Dimon warns investors to avoid stocks and Treasury bonds as rising geopolitical and fiscal risks threaten global markets.
Posted by Prasenjit Bhowmik July 24, 2026
Jamie Dimon Warns Against Buying Stocks and Treasuries Amid Overlooked Market Risks
Posted inEmerging Market

Jamie Dimon Warns Against Buying Stocks and Treasuries Amid Overlooked Market Risks

JPMorgan CEO Jamie Dimon warns investors to avoid stocks and bonds, citing overlooked geopolitical risks and rising inflation.
Posted by Prasenjit Bhowmik July 24, 2026
Jamie Dimon Warns Against Buying Stocks and Treasurys Amid Mounting Fiscal and Geopolitical Risks
Posted inEmerging Market

Jamie Dimon Warns Against Buying Stocks and Treasurys Amid Mounting Fiscal and Geopolitical Risks

JPMorgan CEO Jamie Dimon warns investors to avoid stocks and bonds due to rising government debt and overlooked geopolitical risks.
Posted by Prasenjit Bhowmik July 24, 2026
Eli Lilly Targets 2027 Approval for Next-Generation Triple-Agonist Obesity Drug Retatrutide
Posted inEmerging Market

Eli Lilly Targets 2027 Approval for Next-Generation Triple-Agonist Obesity Drug Retatrutide

Eli Lilly plans to seek approval for its next-generation obesity drug retatrutide by 2027 following highly successful late-stage clinical trials.
Posted by Prasenjit Bhowmik July 24, 2026

Posts pagination

Previous page 1 2 3 4 5 6 … 18 Next page

Recent Posts

  • Five Microsoft Labs to Transform AI Learning and Innovation Across MAHE
  • India's Next Infrastructure Priority: Quality, Safety and Lifecycle Performance
  • VinFast Highlights the EV Equation That's Often Overlooked
  • Handloom Hackathon 2026 Concludes with Breakthrough Innovations to Modernize India's USD 5 Billion Handloom Industry
  • Finkurve Financial Services Delivers Strong Q1 FY27 Performance with AUM Growing 134.5% YoY to INR 1,270.4 Cr and PAT Rising 65.8% YoY

Recent Comments

No comments to show.

Archives

  • August 2026
  • July 2026
  • June 2026

Categories

  • Business Insights
  • Corporate Updates
  • Economy
  • Emerging Market
  • Market
  • Startup
August 2026
MTWTFSS
 12
3456789
10111213141516
17181920212223
24252627282930
31 
« Jul    
Copyright 2026 — SRK Analytics. All rights reserved.
  • Home
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Contact Us
  • About Us
Scroll to Top
Follow by Email
Facebook
fb-share-icon
X (Twitter)
Post on X
LinkedIn
Share
Instagram
Telegram
WhatsApp
THREADS

Website security powered by MilesWeb